Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, et al
BCA, Bicinchoninic acid
BPC 157 has been investigated for its potential role in modulating nitric oxide signaling and vascular growth factor pathways
Retatrutide is an investigational triple receptor agonist developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors, giving it a broader metabolic mechanism than single- or dual-pathway therapies
Enhanced Mobility : Tb-4/Tb-5 specifically aids in restoring flexibility and reducing post-op stiffness
Low glutathione levels are not just linked to aging, but also to higher levels of oxidative damage and lower levels of intracellular antioxidants, which are commonly found in aged individuals (3)